SureTrader
Home > Boards > US Listed > Medical - Healthcare >

Acasti Pharma, Inc (ACST)

ACST RSS Feed
Add ACST Price Alert      Hide Sticky   Hide Intro
Moderator: I.B.Broke, difumetti
Search This Board: 
Last Post: 1/22/2018 8:58:26 AM - Followers: 39 - Board type: Free - Posts Today: 1

Acasti Pharma is a biopharmaceutical innovator advancing a potentially best-in-class cardiovascular drug, CaPre®, for the treatment of hypertriglyceridemia, a chronic condition affecting an estimated one-third of the U.S. population.

Established in August 2008, Acasti is focused on addressing an important market need for an effective, safe and well-absorbed omega-3 therapeutic that can address a patient’s lipid profile — making a positive impact on the major lipids associated with cardiovascular disease risk.


 
 


President and CEO 
Jan D'Alvise
LinkedIn


 

Acasti’s Phase 3-ready investigational candidate CaPre® will be the first pharmaceutical omega-3 product sourced from krill oil. CaPre® has successfully completed phase 1 and 2 trials for the treatment of hypertriglyceridemia, a common metabolic condition characterized by high levels of triglycerides in the blood stream.

The American Heart Association has estimated that one-third of the U.S. population has elevated levels of triglycerides.

 

CaPre’s concentrated omega-3s from krill oil are absorbed into the body more efficiently than those from fish oils, enhancing bioavailability and providing benefits to a patient’s total lipid profile. That means that CaPre® doesn’t just lower triglycerides; it also has shown in clinical trials to have beneficial effects on “good” and “bad” cholesterol levels that affect heart health.
 


Laval, Québec, CANADA, Sept. 14, 2016 Acasti Pharma (NASDAQ:ACST TSX-V:APO) today announced that its bridging study for novel drug candidate CaPre® (omega-3 phospholipid) has successfully met its objectives, supporting Acasti’s strategy to pursue the U.S. Food and Drug Administration’s (FDA) 505(b)(2) regulatory pathway for approval. Acasti is developing CaPre for the treatment of patients with severe hypertriglyceridemia, a metabolic condition that contributes to increased risk of cardiovascular disease and pancreatitis. The 505(b)(2) regulatory pathway allows Acasti to streamline the overall development program required to support a New Drug Application (NDA) by relying on the safety data of an approved drug. 



Laval, Québec, CANADA, October 26, 2016 — Acasti Pharma (NASDAQ:ACST TSX-V:APO) today announced that the United States Patent and Trademark Office issued Acasti a patent (U.S. patent no. 9,475,830) directed to a method of treating hypertriglyceridemia by the administration of a concentrated phospholipid composition. 
This newly issued patent expands Acasti’s intellectual property portfolio related to concentrated therapeutic phospholipid omega-3 compositions covering methods for treating or preventing diseases associated with or related to cardiovascular disease. 

 
 


 







SureTrader
ACST
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ACST News: Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) 01/18/2018 03:30:16 PM
ACST News: Report of Foreign Issuer (6-k) 01/16/2018 08:02:06 AM
ACST News: Report of Foreign Issuer (6-k) 01/08/2018 07:12:23 AM
ACST News: Report of Foreign Issuer (6-k) 01/04/2018 08:02:20 AM
ACST News: Report of Foreign Issuer (6-k) 01/02/2018 08:22:12 AM
PostSubject
#373  Sticky Note ACST ..Acasti Pharma Price Target Announced at $7.00/Share caloosa 01/07/18 09:30:01 AM
#387   Up Pre-Market ..$$$ caloosa 01/22/18 08:58:26 AM
#386   No news. I removed that post because after I.B.Broke 01/18/18 11:31:00 AM
#385   What kind news tomorrow????????? Cheers PJO 01/18/18 11:19:17 AM
#383   ACST..$$$ Going North $$$ caloosa 01/17/18 04:15:47 PM
#382   ACST Will be a Blockbuster $$$$$ caloosa 01/17/18 10:24:30 AM
#381   Arrow Capital Management portfolio manager Alex Ruus discusses I.B.Broke 01/17/18 10:08:06 AM
#380   $ACST on the move up pre-market I.B.Broke 01/17/18 09:30:03 AM
#379   Government recruitment website for the CaPre Phase 3 I.B.Broke 01/12/18 09:17:33 PM
#378   Some quotes from the biotech conference in San Francisco: I.B.Broke 01/10/18 09:13:54 PM
#377   Here's the current state of facts, more update keekee 01/08/18 02:52:20 PM
#376   ACST...The calm before the storm ... caloosa 01/08/18 11:21:18 AM
#375   ACST...Yes indeed , it will be a very caloosa 01/08/18 07:58:57 AM
#374   $ACST is going to flyyyy. The deal they I.B.Broke 01/07/18 07:08:58 PM
#373   ACST ..Acasti Pharma Price Target Announced at $7.00/Share caloosa 01/07/18 09:30:01 AM
#372   This is great news ,Thanks I.B Broke $$$ caloosa 01/06/18 10:59:06 AM
#371   I'll take 2 Up3Stacks 01/05/18 08:00:08 PM
#370   Just got a confirmation email from Glen Akselrod(Investor I.B.Broke 01/05/18 07:51:22 PM
#369   11/20/17...It was $3.3565 .... caloosa 01/05/18 03:34:35 PM
#368   Don't know about $7.00 but $2.50 $3.00 yes caloosa 01/05/18 03:29:25 PM
#367   Also saw they have an event next week? keekee 01/05/18 11:18:40 AM
#366   Just checking upgrades and downgrades and saw someone keekee 01/05/18 11:15:53 AM
#365   ACST up 4% on TXSV ...Canada ... caloosa 01/04/18 02:25:44 PM
#364   Wish I have more Dry Powder !!!...ACST caloosa 01/04/18 09:57:55 AM
#363   These patents are the next step to secure I.B.Broke 01/04/18 09:54:52 AM
#362   ACST ....Here we go $2.OO soon ,very soon .... caloosa 01/04/18 09:19:30 AM
#361   Acasti Expands Global Patent Portfolio with Newly Granted I.B.Broke 01/04/18 08:14:45 AM
#360   Acasti Pharma To Present at Biotech Showcase Conference I.B.Broke 01/02/18 07:43:39 PM
#359   Nothing going on here .... caloosa 12/28/17 08:38:26 AM
#358   Hmm could he but don’t hold ur breathe tabuhasna 12/22/17 10:38:33 AM
#357   1.20 is doable maybe today. we get scaptrader1297 12/22/17 08:48:16 AM
#356   lol Now claytrader doing videos on ACST guess tabuhasna 12/21/17 05:16:01 PM
#355   * * $ACST Video Chart 12-21-17 * * ClayTrader 12/21/17 05:13:15 PM
#354   to be honest watch it in after scaptrader1297 12/21/17 01:07:01 PM
#353   Maybe tomorrow you never know since 3day weekend tabuhasna 12/21/17 12:56:18 PM
#352   I'm looking for 1.20 sell.. few days scaptrader1297 12/21/17 12:55:21 PM
#351   Good for you Mate ,below $1.00 it's a caloosa 12/21/17 12:39:49 PM
#350   Hey can hope right? Lol @ .70 then tabuhasna 12/21/17 11:39:34 AM
#349   now that would be nice. lol scaptrader1297 12/21/17 11:37:49 AM
#348   Boy, I can't even watch this. This was keekee 12/21/17 11:31:12 AM
#347   I should have placed 20k trade at $0.85. keekee 12/21/17 11:27:52 AM
#346   Lol.... I’m ready if it goes to .70 lol tabuhasna 12/21/17 09:18:59 AM
#345   bt 25k at .89 took a while scaptrader1297 12/21/17 09:16:37 AM
#344   Bought @ .90 6000 shares extra lol it’s tabuhasna 12/21/17 09:08:21 AM
#343   Buy Buy Buy ...0.92 caloosa 12/21/17 08:33:04 AM
#342   ACST get them cheeeeap tabuhasna 12/20/17 09:12:09 AM
#340   http://stockcharts.com/h-sc/ui?s=acst&p=D&yr=0&mn=12&dy=0&id=p38090673899 surf1944 12/07/17 08:22:56 PM
#339   ACST buy 1.4500 stocktrademan 12/07/17 11:24:15 AM
#338   Added some more $1.44 ...... caloosa 12/07/17 10:17:46 AM
#337   $ACST just needs to provide the required documents I.B.Broke 11/30/17 02:06:34 PM
#336   should move soon what do you think? scaptrader1297 11/30/17 12:59:04 PM
PostSubject